These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21251210)

  • 1. Identification of protein targets underlying dietary nitrate-induced protection against doxorubicin cardiotoxicity.
    Xi L; Zhu SG; Hobbs DC; Kukreja RC
    J Cell Mol Med; 2011 Nov; 15(11):2512-24. PubMed ID: 21251210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid reduces doxorubicin-induced cardiomyopathy by modulating endothelial nitric oxide synthase.
    Octavia Y; Kararigas G; de Boer M; Chrifi I; Kietadisorn R; Swinnen M; Duimel H; Verheyen FK; Brandt MM; Fliegner D; Cheng C; Janssens S; Duncker DJ; Moens AL
    J Cell Mol Med; 2017 Dec; 21(12):3277-3287. PubMed ID: 28608983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary nitrate supplementation protects against Doxorubicin-induced cardiomyopathy by improving mitochondrial function.
    Zhu SG; Kukreja RC; Das A; Chen Q; Lesnefsky EJ; Xi L
    J Am Coll Cardiol; 2011 May; 57(21):2181-9. PubMed ID: 21596234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect.
    Koka S; Das A; Zhu SG; Durrant D; Xi L; Kukreja RC
    J Pharmacol Exp Ther; 2010 Sep; 334(3):1023-30. PubMed ID: 20543097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications.
    Xi L; Zhu SG; Das A; Chen Q; Durrant D; Hobbs DC; Lesnefsky EJ; Kukreja RC
    Nitric Oxide; 2012 May; 26(4):274-84. PubMed ID: 22484629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198).
    Cai C; Lothstein L; Morrison RR; Hofmann PA
    J Pharmacol Exp Ther; 2010 Oct; 335(1):223-30. PubMed ID: 20668052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.
    Kim KH; Oudit GY; Backx PH
    J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid.
    Ghibu S; Delemasure S; Richard C; Guilland JC; Martin L; Gambert S; Rochette L; Vergely C
    Biochimie; 2012 Apr; 94(4):932-9. PubMed ID: 21396425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphocreatine attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and activating TAK1 to promote myocardial survival in vivo and in vitro.
    Wang C; Hu L; Guo S; Yao Q; Liu X; Zhang B; Meng X; Yang X
    Toxicology; 2021 Aug; 460():152881. PubMed ID: 34358621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
    Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
    Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cytochrome C oxidase-va is possibly involved in metallothionein protection from doxorubicin cardiotoxicity.
    Merten KE; Feng W; Zhang L; Pierce W; Cai J; Klein JB; Kang YJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1314-9. PubMed ID: 16144979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acacia hydaspica R. Parker prevents doxorubicin-induced cardiac injury by attenuation of oxidative stress and structural Cardiomyocyte alterations in rats.
    Afsar T; Razak S; Batoo KM; Khan MR
    BMC Complement Altern Med; 2017 Dec; 17(1):554. PubMed ID: 29284479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sesamin ameliorates doxorubicin-induced cardiotoxicity: involvement of Sirt1 and Mn-SOD pathway.
    Su S; Li Q; Liu Y; Xiong C; Li J; Zhang R; Niu Y; Zhao L; Wang Y; Guo H
    Toxicol Lett; 2014 Jan; 224(2):257-63. PubMed ID: 24211423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
    Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
    Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
    Mantawy EM; El-Bakly WM; Esmat A; Badr AM; El-Demerdash E
    Eur J Pharmacol; 2014 Apr; 728():107-18. PubMed ID: 24509133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity.
    Fan GC; Zhou X; Wang X; Song G; Qian J; Nicolaou P; Chen G; Ren X; Kranias EG
    Circ Res; 2008 Nov; 103(11):1270-9. PubMed ID: 18948619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
    Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
    Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulforaphane protects the heart from doxorubicin-induced toxicity.
    Singh P; Sharma R; McElhanon K; Allen CD; Megyesi JK; Beneš H; Singh SP
    Free Radic Biol Med; 2015 Sep; 86():90-101. PubMed ID: 26025579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
    Mohamed HE; Asker ME; Ali SI; el-Fattah TM
    J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.
    Mukhopadhyay P; Rajesh M; Bátkai S; Kashiwaya Y; Haskó G; Liaudet L; Szabó C; Pacher P
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1466-83. PubMed ID: 19286953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.